SCHEMBL23833210

SCHEMBL23833210

O=C(O)C1=CC=CC=NC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31185706 0.71
SCHEMBL4696439 0.62
SCHEMBL4486855 0.61
SCHEMBL23833208 0.60
SCHEMBL23833213 0.60
SCHEMBL19750859 0.58 TSHR (0.35)
SCHEMBL4899176 0.56
SCHEMBL7856939 0.56
SCHEMBL4637663 0.55
SCHEMBL27586179 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016942-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-01-18 US disclosed
CN-117126231-A Peptoid STAT protein degradation agent, composition and application thereof 杭州和正医药有限公司 2023-11-28 CN disclosed
CN-116490069-A STAT degradation agent and application thereof 凯麦拉医疗公司 2023-07-25 CN disclosed
CN-115776891-A STAT degradants and uses thereof 凯麦拉医疗公司 2023-03-10 CN disclosed
EP-4121055-A1 STAT DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-01-25 EP disclosed
CN-114269763-A Small molecule degradant for STAT3 美国密歇根州立大学试剂中心 2022-04-01 CN disclosed
WO-2021188696-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed
CN-107709305-B Novel compound 葛兰素史克知识产权开发有限公司 2020-09-29 CN disclosed